Turn Therapeutics Inc.
Turn Therapeutics Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Assets Current | |||||||||
Cash Equivalents At Carrying Value | 10 | 11 | 5 | 3 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | |||||
Assets Current | 10 | 11 | 5 | 3 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | |||||
Deferred Costs | 6 | 6 | 6 | - | |||||
Security Deposit | 0 | 0 | 0 | 0 | |||||
Assets | 17 | 19 | 12 | 4 | |||||
Liabilities And Stockhold… | |||||||||
Liabilities Current | |||||||||
Accounts Payable And Other Accrued Liabilities Cur… | 3 | 2 | 3 | 2 | |||||
Derivative Liabilities Current | 6 | 3 | 3 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 9 | 5 | 6 | 2 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | |||||
Long Term Debt Noncurrent | 6 | 6 | - | - | |||||
Contract With Customer Liability Noncurrent | 1 | 1 | 1 | 1 | |||||
Liabilities | 16 | 13 | 7 | 4 | |||||
Stockholders Equity | |||||||||
Common Stock Value | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 30 | 29 | 28 | 23 | |||||
Stockholders Equity Note Subscriptions Receivable | - | - | -1 | -0 | |||||
Retained Earnings Accumulated Deficit | -29 | -23 | -22 | -23 | |||||
Stockholders Equity | 1 | 6 | 5 | 1 | |||||
Liabilities And Stockholders Equity | 17 | 19 | 12 | 4 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 30 | 30 | 29 | 28 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 36.08% | 83.51% | 112.63% | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | - | - | - | 5.38% | 14.67% | 0.73% | 10.78% | 60.31% | 83.44% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Turn Therapeutics Inc. (TTRX) — SEC Financial Statements & Analysis
Turn Therapeutics Inc. (TTRX) is a pharmaceutical preparations company, incorporated in DE. Turn Therapeutics Inc. trades on Nasdaq as: TTRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Turn Therapeutics Inc. reported a Debt-to-Equity ratio of 23.69x, a Price-to-Book (P/B) ratio of 316.58x (TTM), at a market cap of $217.45M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 23.69x
- P/B TTM
- 316.58x
- Market Cap
- $217.45M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Turn Therapeutics Inc. in?
Turn Therapeutics Inc. (TTRX) operates in the Pharmaceutical Preparations industry.
What is TTRX's market cap?
Turn Therapeutics Inc. (TTRX) has a market capitalization of $217.45M as of 2026-06-30.
What exchange does TTRX trade on?
Turn Therapeutics Inc. (TTRX) trades on the Nasdaq.
Where is Turn Therapeutics Inc. incorporated?
Turn Therapeutics Inc. is incorporated in DE.